The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Abstract
Purpose: To provide evidence-based recommendations to oncologists and others for treatment of patients with locally advanced, unresectable pancreatic cancer. Methods: American Society of Clinical Oncology convened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, and advocacy experts and conducted a systematic review of the literature from January 2002 to June 2015. Outcomes included overall survival, disease-free survival, progression-free survival, and adverse events. Results: Twenty-six randomized controlled trials met the systematic review criteria. Recommendations: A multiphase computed tomography scan of the chest, abdomen, and pelvis should be performed. Baseline performance status and comorbidity profile should be evaluated. The goals of care, patient preferences, psychological status, support systems, and symptoms should guide decisions for treatments. A palliative care referral should occur at first visit. Initial systemic chemotherapy (6 months) with a combination regimen is recommended for most patients (for some patients radiation therapy may be offered up front) with Eastern Cooperative Oncology Group performance status 0 or 1 and a favorable comorbidity profile. There is no clear evidence to support one regimen over another. The gemcitabine-based combinations and treatments recommended in the metastatic setting (eg, fluorouracil, leucovorin, irinotecan, and oxaliplatin and gemcitabine plus nanoparticle albumin-bound paclitaxel) have not been evaluated in randomized controlled trials involving locally advanced, unresectable pancreatic cancer. If there is local disease progression after induction chemotherapy, without metastasis, then radiation therapy or stereotactic body radiotherapy may be offered also with an Eastern Cooperative Oncology Group performance status ≤ 2 and an adequate comorbidity profile. If there is stable disease after 6 months of induction chemotherapy but unacceptable toxicities, radiation therapy may be offered as an alternative. Patients with disease progression should be offered treatment per the ASCO Metastatic Pancreatic Cancer Treatment Guideline. Follow-up visits every 3 to 4 months are recommended. Additional information is available at www.asco.org/guidelines/LAPC and www.asco.org/guidelines/MetPC and www.asco.org/guidelineswiki .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Self-citationEpstein, R. M., & Street, R. L. (2007) · PsycEXTRA Dataset · doi:10.1037/e481972008-001 · Cited by 1,590
Gillen, S., Schuster, T., Meyer zum Büschenfelde, C., Friess, H., & Kleeff, J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000267 · Cited by 1,552
Lyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Self-citationIacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7188 · Cited by 1,081
Self-citationKindler, H. L., Niedzwiecki, D., Hollis, D., Sutherland, S., Schrag, D., Hurwitz, H., Innocenti, F., Mulcahy, M. F., O'Reilly, E., Wozniak, T. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1386 · Cited by 845
Loehrer, P. J., Feng, Y., Cardenes, H., Wagner, L., Brell, J. M., Cella, D., Flynn, P., Ramanathan, R. K., Crane, C. H., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8904 · Cited by 830
Self-citationCunningham, D., Chau, I., Stocken, D. D., Valle, J. W., Smith, D., Steward, W., Harper, P. G., Dunn, J., Tudur-Smith, C., West, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2446 · Cited by 823
Berlin, J. D., Catalano, P., Thomas, J. P., Kugler, J. W., Haller, D. G., & Benson, A. B. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.149 · Cited by 729
Self-citationChauffert, B., Mornex, F., Bonnetain, F., Rougier, P., Mariette, C., Bouché, O., Bosset, J. F., Aparicio, T., Mineur, L., Azzedine, A., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn281 · Cited by 696
Heinemann, V., Quietzsch, D., Gieseler, F., Gonnermann, M., Schönekäs, H., Rost, A., Neuhaus, H., Haag, C., Clemens, M., Heinrich, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1490 · Cited by 683
Philip, P. A., Benedetti, J., Corless, C. L., Wong, R., O'Reilly, E. M., Flynn, P. J., Rowland, K. M., Atkins, J. N., Mirtsching, B. C., Rivkin, S. E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7550 · Cited by 632
Self-citationUeno, H., Ioka, T., Ikeda, M., Ohkawa, S., Yanagimoto, H., Boku, N., Fukutomi, A., Sugimori, K., Baba, H., Yamao, K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.3680 · Cited by 628
Herrmann, R., Bodoky, G., Ruhstaller, T., Glimelius, B., Bajetta, E., Schüller, J., Saletti, P., Bauer, J., Figer, A., Pestalozzi, B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0886 · Cited by 595
Rocha Lima, C. M., Green, M. R., Rotche, R., Miller, W. H., Jeffrey, G. M., Cisar, L. A., Morganti, A., Orlando, N., Gruia, G., & Miller, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.082 · Cited by 588
Herman, J. M., Chang, D. T., Goodman, K. A., Dholakia, A. S., Raman, S. P., Hacker‐Prietz, A., Iacobuzio‐Donahue, C. A., Griffith, M. E., Pawlik, T. M., Pai, J. S., et al. (2015) · Cancer · doi:10.1002/cncr.29161 · Cited by 542
Self-citationWong, G. Y., Schroeder, D. R., Carns, P. E., Wilson, J. L., Martin, D. P., Kinney, M. O., Mantilla, C. B., & Warner, D. O. (2004) · JAMA · doi:10.1001/jama.291.9.1092 · Cited by 506
Gourgou-Bourgade, S., Bascoul-Mollevi, C., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Boige, V., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.4869 · Cited by 501
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
Koong, A. C., Le, Q. T., Ho, A., Fong, B., Fisher, G., Cho, C., Ford, J., Poen, J., Gibbs, I. C., Mehta, V. K., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.004 · Cited by 444
Venous thromboembolism and prognosis in cancer
Khorana, A. A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.023 · Cited by 410
Self-citationTissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer
Khorana, A. A., Ahrendt, S. A., Ryan, C. K., Francis, C. W., Hruban, R. H., Hu, Y. C., Hostetter, G., Harvey, J., & Taubman, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2351 · Cited by 394
Self-citationStereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K. A., Fisher, G. A., Ford, J. M., Desser, T., Quon, A., & Koong, A. C. (2009) · Cancer · doi:10.1002/cncr.24059 · Cited by 379
Mukherjee, S., Hurt, C. N., Bridgewater, J., Falk, S., Cummins, S., Wasan, H., Crosby, T., Jephcott, C., Roy, R., Radhakrishna, G., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70021-4 · Cited by 355
Self-citationPhase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
Hoyer, M., Roed, H., Sengelov, L., Traberg, A., Ohlhuis, L., Pedersen, J., Nellemann, H., Kiil Berthelsen, A., Eberholst, F., Engelholm, S. A., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.022 · Cited by 353
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
Maraveyas, A., Waters, J., Roy, R., Fyfe, D., Propper, D., Lofts, F., Sgouros, J., Gardiner, E., Wedgwood, K., Ettelaie, C., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.017 · Cited by 316
Colucci, G., Labianca, R., Di Costanzo, F., Gebbia, V., Cartenì, G., Massidda, B., Dapretto, E., Manzione, L., Piazza, E., Sannicolò, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4433 · Cited by 304
Crane, C. H., Varadhachary, G. R., Yordy, J. S., Staerkel, G. A., Javle, M. M., Safran, H., Haque, W., Hobbs, B. D., Krishnan, S., Fleming, J. B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8038 · Cited by 288
Self-citationPawlik, T. M., Laheru, D., Hruban, R. H., Coleman, J., Wolfgang, C. L., Campbell, K., Ali, S., Fishman, E. K., Schulick, R. D., Herman, J. M., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9929-7 · Cited by 273
Self-citationSchellenberg, D., Kim, J., Christman-Skieller, C., Chun, C. L., Columbo, L. A., Ford, J. M., Fisher, G. A., Kunz, P. L., Van Dam, J., Quon, A., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.006 · Cited by 253
Mahadevan, A., Miksad, R., Goldstein, M., Sullivan, R., Bullock, A., Buchbinder, E., Pleskow, D., Sawhney, M., Kent, T., Vollmer, C., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.04.045 · Cited by 226
(2008) · Cited by 225
Gonçalves, A., Gilabert, M., François, E., Dahan, L., Perrier, H., Lamy, R., Re, D., Largillier, R., Gasmi, M., Tchiknavorian, X., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds135 · Cited by 225
Stathopoulos, G. P., Syrigos, K., Aravantinos, G., Polyzos, A., Papakotoulas, P., Fountzilas, G., Potamianou, A., Ziras, N., Boukovinas, J., Varthalitis, J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603301 · Cited by 198
Herman, J. M., Wild, A. T., Wang, H., Tran, P. T., Chang, K. J., Taylor, G. E., Donehower, R. C., Pawlik, T. M., Ziegler, M. A., Cai, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.7516 · Cited by 186
Self-citationShiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Maire, F., Hammel, P., Ponsot, P., Aubert, A., O'Toole, D., Hentic, O., Levy, P., & Ruszniewski, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00559.x · Cited by 181
Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas
Rwigema, J.-C. M., Parikh, S. D., Heron, D. E., Howell, M., Zeh, H., Moser, A. J., Bahary, N., Quinn, A., & Burton, S. A. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181d270b4 · Cited by 165
Moningi, S., Dholakia, A. S., Raman, S. P., Blackford, A., Cameron, J. L., Le, D. T., De Jesus-Acosta, A. M. C., Hacker-Prietz, A., Rosati, L. M., Assadi, R. K., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4274-5 · Cited by 163
Self-citationDale, W., Hemmerich, J., Kamm, A., Posner, M. C., Matthews, J. B., Rothman, R., Palakodeti, A., & Roggin, K. K. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000226 · Cited by 158
Maisey, N. R., Chau, I., Cunningham, D., Norman, A. R., Seymour, M., Hickish, T., Iveson, T. J., O'Brien, M. E. R., Tebbutt, N. C., Harrington, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.029 · Cited by 136
Heinemann, V., Vehling‐Kaiser, U., Waldschmidt, D., Kettner, E., Märten, A., Winkelmann, C., Klein, S., Kojouharoff, G., Gauler, T. C., von Weikersthal, L. F., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302759 · Cited by 124
Bernhard, J., Dietrich, D., Scheithauer, W., Gerber, D., Bodoky, G., Ruhstaller, T., Glimelius, B. L. G., Bajetta, E., Schueller, J., Saletti, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6240 · Cited by 111
Racial and Ethnic Disparities in Care: The Perspectives of Cardiologists
Lurie, N., Fremont, A., Jain, A. K., Taylor, S. L., McLaughlin, R., Peterson, E., Kong, B. W., & Ferguson, T. B. (2005) · Circulation · doi:10.1161/01.cir.0000157738.12783.71 · Cited by 109
Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy.
Boulay, B. R., & Parepally, M. (2014) · PubMed Central · doi:10.3748/wjg.v20.i28.9345 · Cited by 101
Krzyzanowska, M. K., Weeks, J. C., & Earle, C. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.007 · Cited by 99
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis
Zhu, C., Shi, J., Chen, Y.-X., Xie, W., & Lin, Y. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.04.001 · Cited by 89
Cost‐effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer
Murphy, J. D., Chang, D. T., Abelson, J., Daly, M. E., Yeung, H. N., Nelson, L. M., & Koong, A. C. (2011) · Cancer · doi:10.1002/cncr.26365 · Cited by 68
Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study
Kasenda, B., Bass, A., Koeberle, D., Pestalozzi, B. C., Borner, M., Herrmann, R., Jost, L. M., Lohri, A., & Hess, V. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-728 · Cited by 56
Walters, D. M., LaPar, D. J., de Lange, E. E., Sarti, M., Stokes, J. B., Adams, R. B., & Bauer, T. W. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1693-4 · Cited by 55
Valero, V., Saunders, T., He, J. P., Weiss, M. J., Cameron, J. L., Dholakia, A. S., Wild, A. T., Shin, E. J., Khashab, M. A., Lennon, A. M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001156 · Cited by 55
Self-citationPancreatic Cancer in the USA: Persistence of Undertreatment and Poor Outcome
Enewold, L., Harlan, L. C., Tucker, T. C., & McKenzie, S. P. (2014) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-014-9668-x · Cited by 47
Hurt, C. N., Mukherjee, S., Bridgewater, J. A., Falk, S. J., Crosby, T. D. L., McDonald, A. C., Joseph, G., Staffurth, J. N., Abrams, R. A., Blazeby, J. M., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.08.026 · Cited by 41
Self-citationLamont, E. B., Schilsky, R. L., He, Y., Muss, H. B., Cohen, H. J., Hurria, A., Meilleur, A., Kindler, H. L., Venook, A. P., Lilenbaum, R., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju336 · Cited by 36
Multidisciplinary Management of Pancreatic Cancer
Kumar, R., Herman, J. M., Wolfgang, C. L., & Zheng, L. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2012.12.003 · Cited by 34
Self-citationBoeck, S. H., Vehling‐Kaiser, U., Waldschmidt, D., Kettner, E., Märten, A., Winkelmann, C., Klein, S., Kojouharoff, G., Gauler, T. C., von Weikersthal, L. F., et al. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833123ed · Cited by 34
Sunamura, M., Karasawa, K., Okamoto, A., Ogata, Y., Nemoto, K., Hosotani, R., Nishimura, Y., Matsui, K., & Matsuno, S. (2004) · Pancreas · doi:10.1097/00006676-200404000-00023 · Cited by 28
Pancreatic enzyme supplementation in pancreatic cancer.
Damerla, V., Gotlieb, V., Larson, H., & Saif, M. W. (2008) · PubMed · Cited by 26
Parekh, A., Rosati, L. M., Chang, D. T., Goodman, K. A., Koong, A. C., & Herman, J. M. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.884 · Cited by 6
Self-citation
Cited by
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
Elta, G. H., Enestvedt, B. K., Sauer, B. G., & Lennon, A. M. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.14 · Cited by 719
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Grossberg, A. J., Chu, L. C., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., et al. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21626 · Cited by 489
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Hegde, S., Krisnawan, V. E., Herzog, B. H., Zuo, C., Breden, M. A., Knolhoff, B. L., Hogg, G. D., Tang, J. P., Baer, J. M., Mpoy, C., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.008 · Cited by 463
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Gemenetzis, G., Groot, V. P., Blair, A. B., Laheru, D. A., Zheng, L., Narang, A. K., Fishman, E. K., Hruban, R. H., Yu, J., Burkhart, R. A., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002753 · Cited by 401
Metadata
- Authors
- Balaban, E. P., Mangu, P. B., Khorana, A. A., Shah, M. A., Mukherjee, S., Crane, C. H., Javle, M. M., Eads, J. R., Allen, P., Ko, A. H., Engebretson, A., Herman, J. M., Strickler, J. H., Benson, A. B., Urba, S., & Yee, N. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-08-01
- Volume
- 34
- Issue
- 22
- Pages
- 2654-2668
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2413386818
- Cited by
- 381
- References
- 62
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.